4/A
Changes in Ownership
AXIM BIOTECHNOLOGIES, INC. Filed Acc 0001096906-24-000525
Options or other derivatives
- Chief Executive Officer acquired 500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| HUEMOELLER JOHN WALTER II Chief Executive Officer | 2024-03-15 | Grant or award · Convertible Note | +250,000 | $250,000.00 | $62,500,000,000 | 30,000,000 | D |
| HUEMOELLER JOHN WALTER II Chief Executive Officer | 2024-03-15 | Grant or award · Convertible Note | +250,000 | $250,000.00 | $62,500,000,000 | 42,500,000 | D |
Loading xslF345X05/form4.xml…